title: Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
abstract: Nephrogenic systemic fibrosis (NSF) is a fibrotic disease seen in renal failure patients that may lead to severe physical disability. It has been demonstrated in recent studies that NSF can be caused by some gadolinium-containing MRI contrast agents. In this report we present one of a total of 26 cases of gadodiamide-related NSF from our hospital.
authors.affiliation: Department of Nephrology, Copenhagen University Hospital Herlev, Herlev, Denmark.
authors.forename: Misbah
authors.initials: M
authors.lastname: Khurram
authors.forename: Lone
authors.initials: L
authors.lastname: Skov
authors.forename: Kristian
authors.initials: K
authors.lastname: Rossen
authors.forename: Henrik S
authors.initials: HS
authors.lastname: Thomsen
authors.forename: Peter
authors.initials: P
authors.lastname: Marckmann
mesh_terms: D003287:Contrast Media / Q000009:adverse effects; D003937:Diagnosis, Differential; D005260:Female; D005355:Fibrosis; D019786:Gadolinium DTPA / Q000009:adverse effects; D006801:Humans; D007049:Iatrogenic Disease; D008279:Magnetic Resonance Imaging / Q000009:adverse effects* / Q000379:methods; D008875:Middle Aged; D051437:Renal Insufficiency / Q000473:pathology*; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000473:pathology; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology
chemical_list: D003287:Contrast Media; C064925:gadodiamide; D019786:Gadolinium DTPA